Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Resources
Interactive Tools
Sponsored
Biomarker Consortium
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Emerging Therapies in HER 2-Positive Metastatic Breast Cancer
EP. 1: Evolving Landscape of HER2-Targeted Therapy in Breast Cancer
January 11th 2020
EP. 2: Adjuvant Strategies in Early-Stage HER2+ Breast Cancer
January 11th 2020
EP. 3: Impact of the KATHERINE Trial on Early-Stage HER2+ BC
January 11th 2020
EP. 4: Early-Stage HER2+ Breast Cancer: The ATEMPT Trial
January 11th 2020
EP. 5: Overview of Neoadjuvant Therapy in HER2+ Breast Cancer
January 11th 2020
EP. 6: HER2+ BC: Selection and Management of Neoadjuvant Therapy
January 11th 2020
EP. 7: Treatment Strategies for Relapsed/Refractory HER2+ mBC
January 11th 2020
EP. 8: Unmet Needs in the Management of HER2+ mBC
January 11th 2020
EP. 9: HER2+ Breast Cancer: Evolution of Antibody-Drug Conjugates
January 11th 2020
EP. 10: HER2+ mBC: Study Design and Results of DESTINY-Breast01
January 11th 2020
NEXT PAGE
<
1
2
>
PREVIOUS PAGE